Marta Martín - Vega

Dr. Marta Martín - Vega


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2026 in Regenerative Therapy
Verified
Journal Article
Open access
MVMarta Martín - Vega
Marta Martín - Vega
ACAlvaro Gomez Carrion
Alvaro Gomez Carrion
IZIgnacio Zaragoza-García
Ignacio Zaragoza-García
IOIsmael Ortuño-Soriano
Ismael Ortuño-Soriano
AMArian Marcelino-Argemi
Arian Marcelino-Argemi
Ruben Sanchez-GomezRuben Sanchez-Gomez
Ruben Sanchez-Gomez
Osteoarthritis is an increasingly prevalent condition with limited conservative treatments. Platelet-rich plasma (PRP) therapy has gained attention, but its efficacy may depend on the type used. In particular, leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP) formulations may influence outcomes, yet direct comparisons are limited. a systematic literature search and analysis of clinical trials, through PubMed database, were conducted to evaluate the effect of leukocyte – rich and leukocyte – poor platelet rich plasma in the treatment of osteoarthritis. 11 articles were analyzed individually, including both in vivo and in vitro studies, to examine the effect of leukocytes in PRP. This review highlights that current evidence is insufficient to determine whether adding leukocytes to PRP provides a clinical benefit in the treatment of osteoarthritis. Overall, results generally show no significant differences between LR-PRP and LP-PRP, suggesting that both may be effective. Although leukocytes were initially thought to induce inflammation, there is no conclusive evidence that local reactions are directly caused by them. Given the limitations of existing studies, further research is required to clarify the role of leukocytes in PRP therapy.

17 November 2025 in Sports
Verified
Journal Article
Open access
PDF file
Ruben Sanchez-GomezRuben Sanchez-Gomez
Ruben Sanchez-Gomez
Boon Peng ChangBoon Peng Chang
Boon Peng Chang
VLVitali Lipik
Vitali Lipik
PWPaola Andrea Sanz Wozniak
Paola Andrea Sanz Wozniak
DAN IULIAN ALEXEDAN IULIAN ALEXE
DAN IULIAN ALEXE
ACAlvaro Gomez Carrion
Alvaro Gomez Carrion
Aims: Structural lower limb-length discrepancies (LLLD) have been classically associated with the etiology of low back pain. However, their biomechanical effects on lower-limb muscle activity during running remain unclear. This pilot crossover study aimed to evaluate the influence of orthotic interventions—designed to compensate for LLLD and modify foot biomechanics—on the electromyographic (EMG) activity of the contralateral tensor fasciae latae (TFL) in healthy runners. Methods: A total of 41 recreational male and female runners (mean age 32.27 ± 6.09) with structural LLLD were recruited and classified as neutral (Ng), supinated (SPg), or pronated (PRg) based on their foot posture. Surface EMG activity of the TFL in the longer leg was recorded with specific surface electrodes while participants ran on a treadmill at a constant speed of 9 km/h for 3 min. Each subject randomly wore standard orthoses with 5 mm pronating (PRO), supinating (SUP) wedges or orthoses with a heel lift (TAL) to compensate for the shorter leg, alongside the baseline condition (SIN). Results: Perfect reliability (close to 1) was obtained for all measurements. A statistically significant reduction in TFL EMG activity was recorded in the Ng group: SIN 105.64 ± 50.6%MVC vs. PRO 100.16 ± 48.61%MVC (p < 0.05), and SIN vs. TAL 93.49 ± 15.88%MVC (p < 0.001). A significant reduction was also observed in the PRg group: SIN 91.82 ± 40.75%MVC vs. TAL 80.08 ± 31.75%MVC (p < 0.05). Conclusion: Orthotic compensation for LLLD and foot pronation modifications produced measurable changes in TFL EMG activity during running. These findings provide mechanistic insight into the interaction between limb-length asymmetry, foot biomechanics, and proximal muscle activation in runners, and may inform future studies on overuse injuries such as iliotibial band syndrome.

24 June 2026 in Life
Verified
Journal Article
Open access
PDF file
ÁSÁlvaro Saura Sempere
Álvaro Saura Sempere
Ruben Sanchez-GomezRuben Sanchez-Gomez
Ruben Sanchez-Gomez
IOIsmael Ortuño-Soriano
Ismael Ortuño-Soriano
IZIgnacio Zaragoza-García
Ignacio Zaragoza-García
PWPaola Andrea Sanz Wozniak
Paola Andrea Sanz Wozniak
ACAlvaro Gomez Carrion
Alvaro Gomez Carrion
Introduction: Plantar fasciosis is a common degenerative condition characterized by structural alterations of the plantar aponeurosis, including increased thickness and loss of its normal fibrillar pattern. Ultrasound imaging is widely used to assess these changes; however, the validity of plantar aponeurosis thickness as a marker of tissue recovery remains controversial. Dextrose prolotherapy has been proposed as an effective treatment for this condition, although its effects are not yet fully established. In particular, different injection approaches have been described, such as perifascial and intrafascial techniques, whose comparative effectiveness remains unclear. Therefore, the aim of this study was to evaluate longitudinal changes in plantar aponeurosis thickness and fibrillar pattern following treatment with these two prolotherapy approaches. Methods: A total of 56 patients with plantar fasciosis were prospectively evaluated over a one-year period following treatment with 20% dextrose prolotherapy. Ultrasound assessments were performed at multiple time points to measure plantar aponeurosis thickness and to qualitatively evaluate the fibrillar pattern (recovered vs. non-recovered). Longitudinal changes in thickness were analyzed using repeated-measures generalized linear models (GLMs), while differences in fibrillar pattern recovery according to injection technique (intrafascial vs. perifascial) were assessed using the chi-square test and Fisher’s exact test. Results: No significant changes in plantar aponeurosis thickness were observed over the follow-up period (p = 0.260), despite a slight decreasing trend. In contrast, recovery of the fibrillar pattern was observed in 92.9% of patients (52/56) at one year. The recovery rate was significantly higher in the perifascial group (100%) compared to the intrafascial group (80%) (Fisher’s exact test, p = 0.013). Qualitative fibrillar pattern assessment was independently re-evaluated by a blinded second examiner, demonstrating almost perfect inter-rater agreement (Cohen’s κ = 0.83). Conclusions: Dextrose prolotherapy was associated with ultrasonographic evidence of structural tissue remodeling of the plantar aponeurosis, as evidenced by recovery of the fibrillar pattern, without inducing significant changes in thickness. These findings suggest that assessment of the fibrillar pattern may offer additional information regarding structural remodeling following 20% dextrose prolotherapy, whereas plantar aponeurosis thickness remained relatively stable throughout follow-up.